Polychemotherapy with curcumin and doxorubicin via biological nanoplatforms: Enhancing antitumor activity
10.3390/pharmaceutics12111084
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Review |
| Published: |
MDPI AG
2021
|
| Subjects: | |
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/199679 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-199679 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-1996792024-04-04T04:00:31Z Polychemotherapy with curcumin and doxorubicin via biological nanoplatforms: Enhancing antitumor activity Ashrafizadeh, M. Zarrabi, A. Hashemi, F. Zabolian, A. Saleki, H. Bagherian, M. Azami, N. Bejandi, A.K. Hushmandi, K. Ang, H.L. Makvandi, P. Khan, H. Kumar, A.P. PHARMACOLOGY Apoptosis Chemoresistance Curcumin Doxorubicin Nanodelivery Side effect 10.3390/pharmaceutics12111084 Pharmaceutics 12 11 1-36 2021-08-27T02:34:47Z 2021-08-27T02:34:47Z 2020 Review Ashrafizadeh, M., Zarrabi, A., Hashemi, F., Zabolian, A., Saleki, H., Bagherian, M., Azami, N., Bejandi, A.K., Hushmandi, K., Ang, H.L., Makvandi, P., Khan, H., Kumar, A.P. (2020). Polychemotherapy with curcumin and doxorubicin via biological nanoplatforms: Enhancing antitumor activity. Pharmaceutics 12 (11) : 1-36. ScholarBank@NUS Repository. https://doi.org/10.3390/pharmaceutics12111084 1999-4923 https://scholarbank.nus.edu.sg/handle/10635/199679 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ MDPI AG Scopus OA2020 |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| topic |
Apoptosis Chemoresistance Curcumin Doxorubicin Nanodelivery Side effect |
| spellingShingle |
Apoptosis Chemoresistance Curcumin Doxorubicin Nanodelivery Side effect Ashrafizadeh, M. Zarrabi, A. Hashemi, F. Zabolian, A. Saleki, H. Bagherian, M. Azami, N. Bejandi, A.K. Hushmandi, K. Ang, H.L. Makvandi, P. Khan, H. Kumar, A.P. Polychemotherapy with curcumin and doxorubicin via biological nanoplatforms: Enhancing antitumor activity |
| description |
10.3390/pharmaceutics12111084 |
| author2 |
PHARMACOLOGY |
| author_facet |
PHARMACOLOGY Ashrafizadeh, M. Zarrabi, A. Hashemi, F. Zabolian, A. Saleki, H. Bagherian, M. Azami, N. Bejandi, A.K. Hushmandi, K. Ang, H.L. Makvandi, P. Khan, H. Kumar, A.P. |
| format |
Review |
| author |
Ashrafizadeh, M. Zarrabi, A. Hashemi, F. Zabolian, A. Saleki, H. Bagherian, M. Azami, N. Bejandi, A.K. Hushmandi, K. Ang, H.L. Makvandi, P. Khan, H. Kumar, A.P. |
| author_sort |
Ashrafizadeh, M. |
| title |
Polychemotherapy with curcumin and doxorubicin via biological nanoplatforms: Enhancing antitumor activity |
| title_short |
Polychemotherapy with curcumin and doxorubicin via biological nanoplatforms: Enhancing antitumor activity |
| title_full |
Polychemotherapy with curcumin and doxorubicin via biological nanoplatforms: Enhancing antitumor activity |
| title_fullStr |
Polychemotherapy with curcumin and doxorubicin via biological nanoplatforms: Enhancing antitumor activity |
| title_full_unstemmed |
Polychemotherapy with curcumin and doxorubicin via biological nanoplatforms: Enhancing antitumor activity |
| title_sort |
polychemotherapy with curcumin and doxorubicin via biological nanoplatforms: enhancing antitumor activity |
| publisher |
MDPI AG |
| publishDate |
2021 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/199679 |
| _version_ |
1800914998704209920 |